The terms “semaglutide AND PCOS,” “tirzepatide AND PCOS,” “tirzepatide AND insulin resistance,” “GLP-1 receptor agonist AND reproductive disorders,” “GLP-1 receptor agonist AND PCOS,” and “retatrutide” were used. This evidence concerns the gene GLP1R and Insulin resistance.